Evidence map›Paper›PMID 28470464›Full record

ReviewArchivum immunologiae et therapiae experimentalis2017

Expanding Diversity and Common Goal of Regulatory T and B Cells. II: In Allergy, Malignancy, and Transplantation.

Grażyna Korczak-Kowalska, Anna Stelmaszczyk-Emmel, Katarzyna Bocian, Ewelina Kiernozek, Nadzieja Drela, Joanna Domagała-Kulawik

Open access · hybridAbstract readReview
In one paragraph

Review in Archivum immunologiae et therapiae experimentalis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. New Frontiers for Molecular Pathology.Frontiers in medicine · 2019
    Review
  2. Review
  3. CD9Frontiers in immunology · 2018
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Grażyna Korczak-KowalskaDepartment of Immunology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Anna Stelmaszczyk-EmmelDepartment of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.
Katarzyna BocianDepartment of Immunology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Ewelina KiernozekDepartment of Immunology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Nadzieja DrelaDepartment of Immunology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Joanna Domagała-KulawikDepartment Pneumonology, Medical University of Warsaw, Warsaw, Poland. domagalakulawik@gmail.com.
Medical University of Warsaw · PLUniversity of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of immune response was found to play an important role in the course of many diseases such as autoimmune diseases, allergy, malignancy, organ transplantation. The studies on immune regulation focus on the role of regulatory cells (Tregs, Bregs, regulatory myeloid cells) in these disorders. The number and function of Tregs may serve as a marker of disease activity. As in allergy, the depletion of Tregs is observed and the results of allergen-specific immunotherapy could be measured by an increase in the population of IL-10

Indexed as

AnimalsAutoimmunityB-Lymphocytes, RegulatoryGraft RejectionHumansHypersensitivityImmune ToleranceNeoplasmsT-Lymphocytes, RegulatoryTransplantationAllergyCancerMyeloid cellsRegulatory B cellRegulatory T cellTransplantology

Identifiers

PMID28470464
PMCPMC5688211
OpenAlexW2610293096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.